TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16881811

Group type: EXPERIMENTAL
Intervention: Customized interdental brushing technique
Number of subjects: 77

Group type: COMPARATOR
Intervention: Customized flossing technique
Number of subjects: 77
Study: 15592308

Group type: EXPERIMENTAL
Intervention: Misoprostol 200 mug
Number of subjects: 20

Group type: COMPARATOR
Intervention: Methylergometrine 250 mug
Number of subjects: 20
Study: 11352438

Group type: EXPERIMENTAL
Intervention: Fasted condition (moxifloxacin 400mg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Fed condition (moxifloxacin 400mg)
Number of subjects: 18
Study: 11398591

Group type: COMPARATOR
Intervention: Multifrequency bioimpedance spectroscopy analysis (BIS)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: BIS pre-HD measurements
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: BIS post-HD measurements
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: BIS measurements
Number of subjects: 360
Study: 7625347

Group type: COMPARATOR
Intervention: Standard-phosphorus (215 micrograms/kJ, or 90 mg/100 kcal)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Moderate-phosphorus (254 micrograms/kJ, or 106 mg/100 kcal)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: High-phosphorus (287 micrograms/kJ, or 120 mg/100 kcal)
Number of subjects: 35
Study: 2165750

Group type: EXPERIMENTAL
Intervention: Formoterol 20 ng
Number of subjects: 0

Group type: COMPARATOR
Intervention: Terbutaline 500 ng
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Formoterol 0.5 micrograms
Number of subjects: 0

Group type: COMPARATOR
Intervention: Terbutaline 25 micrograms
Number of subjects: 0
Study: 533740

Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise (HIE)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Low-Intensity Exercise (LIE)
Number of subjects: 79
Study: 31907528

Group type: EXPERIMENTAL
Intervention: Polyunsaturated fat
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saturated fat
Number of subjects: 0
Study: 31325379

Group type: COMPARATOR
Intervention: Low RFI ducks (LRFI)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Correlation analysis
Number of subjects: 1000
Study: 28912116

Group type: EXPERIMENTAL
Intervention: Tablet-based EORTC QLQ-C30 questionnaire
Number of subjects: 106

Group type: COMPARATOR
Intervention: Paper-based EORTC QLQ-C30 questionnaire
Number of subjects: 106
Study: 26201227

Group type: COMPARATOR
Intervention: Standard adhesion procedure for direct resin composite restorations (Group 1)
Number of subjects: 648

Group type: EXPERIMENTAL
Intervention: Additional procedure of enamel adhesive on the outer boundary of the finished restoration (Group 2)
Number of subjects: 648
Study: 23557413

Group type: EXPERIMENTAL
Intervention: Multimedia program on parasite infestations (cybertutor)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard classes on parasite infestations
Number of subjects: 50
Study: 22000938

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Perphenazine
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Overall (across medication phases)
Number of subjects: 1332

Group type: EXPERIMENTAL
Intervention: Baseline
Number of subjects: 1332
Study: 19470312

Group type: EXPERIMENTAL
Intervention: Citalopram (19 patients)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (18 patients)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Citalopram and Placebo (both groups)
Number of subjects: 72
Study: 16622703

Group type: EXPERIMENTAL
Intervention: Quick stretch (2 nm per half-sarcomere length) applied to muscle fibers
Number of subjects: 235
Study: 14727018

Group type: EXPERIMENTAL
Intervention: Pressure Support (PS) ventilation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Assist-Control/Volume-Targeted (AC/VT) ventilation
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Increasing back-up rate to Fmax during PS and AC/VT ventilation
Number of subjects: 10

Group type: COMPARATOR
Intervention: Spontaneous breathing
Number of subjects: 10
Study: 11372180

Group type: EXPERIMENTAL
Intervention: Specific acupuncture sites
Number of subjects: 24

Group type: COMPARATOR
Intervention: Unspecific sites (control group, placebo acupuncture)
Number of subjects: 24
Study: 9234562

Group type: EXPERIMENTAL
Intervention: Transurethral incision of prostate (TUIP) - bilateral incision
Number of subjects: 45
Study: 10362410

Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Norepinephrine plus dobutamine (5 microg/kg/min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Norepinephrine
Number of subjects: 12
Study: 2229897

Group type: EXPERIMENTAL
Intervention: Punctum plug treatment on one side
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (simulation insertion)
Number of subjects: 35
Study: 907395

Group type: EXPERIMENTAL
Intervention: Gastric bypass (90% gastric exclusion with Roux-en-Y reconstitution)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Jejunoileal bypass (end-to-end anastomosis between 30 cm of jejunum and 25 cm of terminal ileum)
Number of subjects: 59
Study: 30621105

Group type: COMPARATOR
Intervention: ABCG2 rs72552713
Number of subjects: 521

Group type: COMPARATOR
Intervention: SLC22A12 rs11231825
Number of subjects: 521

Group type: COMPARATOR
Intervention: rs12505410
Number of subjects: 521

Group type: COMPARATOR
Intervention: Serum uric acid and systolic blood pressure
Number of subjects: 521
Study: 28285255

Group type: EXPERIMENTAL
Intervention: 8h time in bed (TIB) restriction with fluoxetine 20-40 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: 6h time in bed (TIB) restriction with fluoxetine 20-40 mg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 6h time in bed (TIB) restriction with delayed bedtime or advanced risetime
Number of subjects: 30
Study: 25417042

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) using a pressure threshold device, 5 sessions weekly for 12 weeks, 30 mins/day
Number of subjects: 46

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 46
Study: 23064222

Group type: EXPERIMENTAL
Intervention: BOC/PEG2a/R
Number of subjects: 201

Group type: COMPARATOR
Intervention: PEG2a/R
Number of subjects: 201
Study: 21747291

Group type: EXPERIMENTAL
Intervention: Betaine supplementation (BET) for 15 days
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo (PL) for 15 days
Number of subjects: 11
Study: 19489257

Group type: EXPERIMENTAL
Intervention: High-pull headgear
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 40
Study: 16942534

Group type: EXPERIMENTAL
Intervention: Sildenafil (100 mg)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Vardenafil (20 mg)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Tadalafil (20 mg)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sildenafil (100 mg) vs Tadalafil (20 mg)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Vardenafil (20 mg) vs Tadalafil (20 mg)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Tadalafil (20 mg) vs Sildenafil (100 mg)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: All drugs
Number of subjects: 132
Study: 16281636

Group type: EXPERIMENTAL
Intervention: Topical corticosteroids
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Cosmetics and skin care products
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Atopic diseases history
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Prick test reactivity
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Specific IgE against aeroallergens
Number of subjects: 200
Study: 11588133

Group type: COMPARATOR
Intervention: Lung cancer cases (n=356)
Number of subjects: 820

Group type: COMPARATOR
Intervention: Prostate cancer cases (n=235)
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: Subpopulation of prostate cancer patients (n=174)
Number of subjects: 820
Study: 9327830

Group type: EXPERIMENTAL
Intervention: Antiplatelet drugs (aspirin, ticlopidine, thromboxane A2 receptor inhibitors)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antithrombotics (heparin, hirudin, hirulog)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ACE inhibitors, HMG‐CoA reductase inhibitors, fish‐oil supplements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antiproliferatives (angiopeptin, trapidil, tranilast)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycoprotein IIb/IIIa receptor antagonists, inhibitors of the early coagulation cascade, calcium channel blockers, nitric oxide donors
Number of subjects: 0
Study: 8514980

Group type: EXPERIMENTAL
Intervention: octreotide
Number of subjects: 20

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 20
Study: 3716740

Group type: COMPARATOR
Intervention: Gastric bypass
Number of subjects: 57

Group type: COMPARATOR
Intervention: Gastroplasty
Number of subjects: 57
Study: 30590843

Group type: EXPERIMENTAL
Intervention: Eye-lens dosemeters (Dosilab, Landauer, IRSN)
Number of subjects: 90
Study: 27355501

Group type: EXPERIMENTAL
Intervention: Active patient follow-up package of interventions including individualized health education, use of flip charts, phone and SMS appointment reminders, active tracking after missed visits, and individualized support.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 0
Study: 24637237

Group type: EXPERIMENTAL
Intervention: Standard smoking-cessation booklet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivation-based booklet designed specifically for USAF personnel
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Motivation-based booklet combined with a brief, face-to-face motivational session
Number of subjects: 0
Study: 22493927

Group type: EXPERIMENTAL
Intervention: New moxibustion‐massage apparatus
Number of subjects: 60

Group type: COMPARATOR
Intervention: Suspended moxibustion
Number of subjects: 60
Study: 20061961

Group type: EXPERIMENTAL
Intervention: Mood Spectrum Self‐Report Questionnaire factors 'depressive mood' and 'psychotic features'
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Panic‐Agoraphobic Spectrum Self‐Report Questionnaire factors 'separation anxiety' and 'loss sensitivity'
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Mood Spectrum Self‐Report Questionnaire factor 'psychomotor retardation'
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Panic‐Agoraphobic Spectrum Self‐Report Questionnaire factor 'fear of losing control'
Number of subjects: 226
Study: 18548088

Group type: EXPERIMENTAL
Intervention: Relaxation therapies
Number of subjects: 1198
Study: 16173850

Group type: EXPERIMENTAL
Intervention: Traditional Behavioral Couple Therapy (TBCT)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Integrative Behavioral Couple Therapy (IBCT)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: TBCT
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: IBCT
Number of subjects: 134
Study: 12592235

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 10099724

Group type: EXPERIMENTAL
Intervention: Portable liquid oxygen therapy (PLOT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Compressed air simulating oxygen
Number of subjects: 30
Study: 8551199

Group type: EXPERIMENTAL
Intervention: 60 degrees retinal photography
Number of subjects: 663

Group type: COMPARATOR
Intervention: One 45 degrees field
Number of subjects: 663

Group type: COMPARATOR
Intervention: Two 45 degrees fields
Number of subjects: 663

Group type: COMPARATOR
Intervention: Ophthalmologist's assessment
Number of subjects: 663
Study: 1879247

Group type: EXPERIMENTAL
Intervention: Colloidal aqueous solution of vitamin E (acetate ester)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Olive oil solution of vitamin E
Number of subjects: 44
Study: 7092487

Group type: EXPERIMENTAL
Intervention: Phenelzine sulfate
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Clorgyline
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Pargyline hydrochloride
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Repeated MAO-inhibitor treatment (crossover study of clorgyline and pargyline)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Bipolar illness patients
Number of subjects: 39

Group type: COMPARATOR
Intervention: Unipolar illness patients
Number of subjects: 39
Study: 31439877

Group type: EXPERIMENTAL
Intervention: 6-week supervised preoperative rehabilitation program
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 65
Study: 30004577

Group type: EXPERIMENTAL
Intervention: Reminder + FIT
Number of subjects: 2144

Group type: COMPARATOR
Intervention: Reminder
Number of subjects: 2144
Study: 26908704

Group type: EXPERIMENTAL
Intervention: Darbepoetin (10 μg/kg, once per week)
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Erythropoietin (400 U/kg, 3 times/week)
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 77

Group type: COMPARATOR
Intervention: Term Controls (TCs)
Number of subjects: 77
Study: 24957712

Group type: EXPERIMENTAL
Intervention: Manual therapy treatment for neck pain
Number of subjects: 181
Study: 23118893

Group type: EXPERIMENTAL
Intervention: Higher TSH levels (Q5)
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Hypothyroid status
Number of subjects: 402

Group type: EXPERIMENTAL
Intervention: Hyperthyroid status
Number of subjects: 402
Study: 19121976

Group type: EXPERIMENTAL
Intervention: Static condition with masseteric excitation at 20%, 40%, 60%, 80%, or 100%
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Dynamic condition with habitual chewing pace and stimuli delivered at predetermined gape
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Responses to mildly painful stimuli during dynamic condition
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Responses to moderately painful stimuli during dynamic condition
Number of subjects: 14
Study: 17537023

Group type: EXPERIMENTAL
Intervention: HL‐350
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control milk (HL‐00)
Number of subjects: 20
Study: 15157727

Group type: EXPERIMENTAL
Intervention: Program of Resources, Information and Support for Mothers (PRISM)
Number of subjects: 6400

Group type: COMPARATOR
Intervention: Comparison group (not specified)
Number of subjects: 6400
Study: 11141226

Group type: EXPERIMENTAL
Intervention: Tiamazole
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 100

Group type: COMPARATOR
Intervention: Beta-blockade (general)
Number of subjects: 100
Study: 9847269

Group type: COMPARATOR
Intervention: Placebo arm of the preventive therapy study
Number of subjects: 4058

Group type: EXPERIMENTAL
Intervention: PPD positive subjects
Number of subjects: 4058

Group type: EXPERIMENTAL
Intervention: MTBCF-stimulated IFN-gamma levels
Number of subjects: 4058
Study: 8018457

Group type: COMPARATOR
Intervention: Angiotensin II infusion (1 ng min‐1 kg‐1)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Indomethacin (200 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Indomethacin pre‐treatment followed by angiotensin II infusion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Frusemide (20 mg) administration
Number of subjects: 8
Study: 2529659

Group type: EXPERIMENTAL
Intervention: Silicone gel sheeting applied for 8 weeks (at least 12 hours a day)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Silicone gel sheeting
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control scars (untreated, mirror-image or adjacent)
Number of subjects: 10
Study: 983797

Group type: EXPERIMENTAL
Intervention: Photon absorptiometry for evaluating bone mineral content
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional X-ray film evaluation of bone mineral
Number of subjects: 73
Study: 31704711

Group type: EXPERIMENTAL
Intervention: Progesterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no progesterone)
Number of subjects: 0
Study: 28545525

Group type: EXPERIMENTAL
Intervention: Tensor group (gap-tensioning device set at 20 lbf)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Measured resection group (externally rotating the axis 3° off the posterior femoral condylar axis)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Block group (spacer blocks of various thicknesses)
Number of subjects: 165

Group type: COMPARATOR
Intervention: All groups (postoperative 2 year clinical results)
Number of subjects: 165
Study: 26490109

Group type: EXPERIMENTAL
Intervention: Game-based rehabilitation program (GRP)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual physical therapy (comparator group)
Number of subjects: 56
Study: 24355115

Group type: EXPERIMENTAL
Intervention: Post-PCI systolic-diastolic range <10°
Number of subjects: 266

Group type: COMPARATOR
Intervention: Pre-PCI diastolic distal BA tertiles (<82°, 82° to 106°, ≥107°)
Number of subjects: 266
Study: 21227454

Group type: EXPERIMENTAL
Intervention: LESS cholecystectomy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Classic laparoscopic cholecystectomy
Number of subjects: 50
Study: 18603026

Group type: EXPERIMENTAL
Intervention: Acetazolamide 250 mg/day
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Acetazolamide 500 mg/day
Number of subjects: 18
Study: 17077421

Group type: EXPERIMENTAL
Intervention: Intervention group (academic detailing)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Enhanced intervention group
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Urban hypertensive patients
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: Combined urban and suburban data
Number of subjects: 165
Study: 15636221

Group type: EXPERIMENTAL
Intervention: Glaucoma patients (trabeculectomy)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (20 operated patients with age-related cataract)
Number of subjects: 48
Study: 11327056

Group type: EXPERIMENTAL
Intervention: Calcium sulfate plus autologous bone graft (test)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bioabsorbable membrane plus autologous bone graft (control)
Number of subjects: 12
Study: 9496009

Group type: EXPERIMENTAL
Intervention: Biofeedback relaxation training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 8196151

Group type: EXPERIMENTAL
Intervention: Pravastatin (5 mg or 10 mg twice a day)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Untreated group (Control)
Number of subjects: 66
Study: 3372432

Group type: EXPERIMENTAL
Intervention: Propranolol (80 mg twice daily)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Atenolol (100 mg once daily)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30535670

Group type: EXPERIMENTAL
Intervention: PR-fampridine 10 mg twice daily
Number of subjects: 636

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 636

Group type: EXPERIMENTAL
Intervention: PR-fampridine
Number of subjects: 636
Study: 28973344

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (20 ppm decreased to 10 ppm between 72 and 96 hours, then to 5 ppm until completion of therapy for 24 days)
Number of subjects: 451

Group type: COMPARATOR
Intervention: Placebo (nitrogen)
Number of subjects: 451

Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide
Number of subjects: 451
Study: 26411885

Group type: EXPERIMENTAL
Intervention: 9vHPV vaccine
Number of subjects: 924

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 924
Study: 24573590

Group type: EXPERIMENTAL
Intervention: Complementation by argon plasma coagulation (group 2)
Number of subjects: 21

Group type: COMPARATOR
Intervention: No additional procedure (group 1)
Number of subjects: 21
Study: 21556911

Group type: EXPERIMENTAL
Intervention: Protocol D (saline chaser at 8 mL/s)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Protocol C (saline chaser at 4 mL/s)
Number of subjects: 100
Study: 18482014

Group type: EXPERIMENTAL
Intervention: RCAC (1% formulation applied twice a day for 28 days)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo (applied twice a day for 28 days)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: RCAC (in vitro treatment)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: RCAC (clinical effectiveness measures)
Number of subjects: 124
Study: 17130317

Group type: EXPERIMENTAL
Intervention: Sequential pneumatic leg pump therapy postoperatively
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no pneumatic leg pump therapy)
Number of subjects: 200
Study: 14636811

Group type: EXPERIMENTAL
Intervention: Pathways intervention
Number of subjects: 1447

Group type: COMPARATOR
Intervention: Control
Number of subjects: 1447
Study: 11007407

Group type: EXPERIMENTAL
Intervention: povidone-iodine
Number of subjects: 30

Group type: COMPARATOR
Intervention: saline
Number of subjects: 30

Group type: COMPARATOR
Intervention: no preparation
Number of subjects: 30
Study: 8928893

Group type: EXPERIMENTAL
Intervention: Double pharmacological autonomic blockade with propranolol (0.2 mg/kg iv) and atropine (0.04 mg/kg iv)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Double pharmacological autonomic blockade with propranolol and atropine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Baseline measurements (no intervention)
Number of subjects: 17
Study: 1471411

Group type: EXPERIMENTAL
Intervention: B subunit‐whole cell vaccine (B‐WC)
Number of subjects: 90000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90000
Study: 6375258

Group type: EXPERIMENTAL
Intervention: Naloxone (0.4 and 2.0 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 17

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 17
Study: 30363012

Group type: EXPERIMENTAL
Intervention: Acupuncture (8 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yoga (10 weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health and wellness education classes (10 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham acupuncture (attention control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 0
Study: 29504877

Group type: EXPERIMENTAL
Intervention: Self-adhesive resin cement (RelyX U100/U200)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Regular resin cement (Single Bond and RelyX ARC)
Number of subjects: 152